Erlotinib-Associated Rash in Advanced Non-Small Cell Lung Cancer: Relation to Clinicopathological Characteristics, Treatment Response, and Survival

Systematic treatment of advanced non-small cell lung cancer (NSCLC) includes targeted treatment with epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs). The development of skin rash and its intensity have been associated with EGFR TKI’s efficacy. The main purpose of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Kainis, Ilias, Syrigos, Nikolaos, Kopitopoulou, Alexandra, Gkiozos, Ioannis, Filiou, Effrosyni, Nikolaou, Vasiliki, Papadavid, Evangelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844560/
https://www.ncbi.nlm.nih.gov/pubmed/28390118
http://dx.doi.org/10.3727/096504017X14913452320194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844560/
https://www.ncbi.nlm.nih.gov/pubmed/28390118
http://dx.doi.org/10.3727/096504017X14913452320194

Ejemplares similares